Picture of Collplant Biotechnologies logo

CLGN — Collplant Biotechnologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Collplant Biotechnologies Reports Q2 Loss Per Share Of $0.28

Aug 28 (Reuters) - Collplant Biotechnologies Ltd  CPTGy.F :
    * COLLPLANT BIOTECHNOLOGIES REPORTS SECOND QUARTER (Q2) 2020
FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.28
    * Q2 REVENUE ROSE 36 PERCENT TO $823,000

Source text for Eikon:  ID:nPn4qWMjWa 
Further company coverage:  CPTGy.F 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Collplant Biotechnologies

See all news